Evaluating Latest Advances in Treatment of VTE: A Year in Review

The goal of this activity is to provide the latest data and recommendations for venous thromboembolism (VTE) prevention in hospitalized patients.
 
Educational Partner: Medscape, LLC
 
Medium: Online Presentation
 
Commercial Support: This activity is supported by an independent educational grant from Janssen Pharmaceuticals, Inc.

Target Audience

This activity is intended for cardiologists, hematology/oncology physicians, and primary care physicians.

Learning Objectives

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Latest data on treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
    • Emerging data on the use of DOACs in the setting of outpatient PE
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
For more information, please contact:
CME Coordinator Contact Name: 
Medscape
CME Coordinator Contact Email: 
AttachmentSize
Postcard499.85 KB
Summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Activity opens: 
12/20/2019
Activity expires: 
12/20/2020
MODERATOR
  Victor F. Tapson, MD
  Professor of Medicine
  Cedars-Sinai Medical Center
  Los Angeles, California, United States
 
PANELIST
  Craig I. Coleman, PharmD
  Professor of Pharmacy Practice
  University of Connecticut
  Storrs, Connecticut, United States
 
 
  Philip Wells, MD, FRCPC
  Chair and Professor
  Department of Medicine
  Ottawa Hospital
  University of Ottawa
  Ottawa, Canada
 
COURSE REVIEWER
  Matthew Sorrentino, MD, FACC, FAHA
  Vice Chair for Clinical Operations
  Department of Medicine
  Section of Cardiology
  University of Chicago Medicine
 
 

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Accreditation Statements
 
Developed through a collaboration between the University of Chicago Medicine and Medscape Education.
 
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Registration: To view this activity, you will need to visit Medscape's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
 
Please login or create an account to proceed.